Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11382893 | 0.84 | HPGD (0.51) | ALDH1A1 | |
| SCHEMBL28005171 | 0.83 | CYP3A4 (0.55) | KDM4EHIF1A | |
| SCHEMBL12511591 | 0.80 | MTNR1A (0.42) | — | |
| SCHEMBL12511583 | 0.80 | EGFR (0.40) | — | |
| SCHEMBL12512402 | 0.80 | MTNR1A (0.42) | — | |
| SCHEMBL30705332 | 0.79 | KDM1A (0.44) | — | |
| Trimethylammonium SCHEMBL28889845 | 0.79 | KDM1A (0.38) | ALDH1A1 | |
| SCHEMBL10674369 | 0.79 | CYP3A4 (0.42) | KDM4EALDH1A1HIF1A | |
| SCHEMBL10674358 | 0.79 | CYP3A4 (0.42) | KDM4EALDH1A1HIF1A | |
| SCHEMBL14922815 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240287009-A1 | AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME | INFINEUM INTERNATIONAL LIMITED (GB) | 2024-08-29 | — | — | US | disclosed |
| EP-4410772-A2 | AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME | Infineum International Limited (GB) | 2024-08-07 | — | — | EP | disclosed |
| CN-118440229-A | Amine functional monomers and methods of making the same | 英菲诺姆国际有限公司 | 2024-08-06 | — | — | CN | disclosed |
| US-20100303877-A1 | Controlled Release Hydrogel Films | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-12-02 | — | — | US | disclosed |
| US-4695631-A | ISOMERIZATION OF AN ALLYLAMINE, RHODIUM COMPLEX CATALYST | TAKASAGO PERFUMERY CO., LTD. (JP) | 1987-09-22 | — | — | US | disclosed |
| EP-0068506-B1 | PROCESS FOR THE PREPARATION OF ENAMINES OR IMINES | Takasago Perfumery Co., Ltd. (JP) | 1984-11-21 | — | — | EP | disclosed |
| EP-0068506-A1 | Process for the preparation of enamines or imines | Takasago Perfumery Co., Ltd. (JP) | 1983-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240287009-A1 | AMINE-FUNCTIONAL MONOMERS AND METHODS OF MAKING SAME | AMD1, HNMT, MAT1A | KDM4E 797/4885ALDH1A1 317/4885HIF1A 4076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.